Prevalence of Anaemia and Review of Associated Factors in Kidney Transplant Recipients: A Retrospective Analysis from a Single United Kingdom (UK) Centre

Background: Renal transplantation is the optimal treatment for end-stage renal disease (ESRD), offering superior survival outcomes compared to dialysis. However, renal transplant recipients (RTRs) remain at high risk of anaemia, which may affect graft function and patient morbidity. This study assessed the prevalence of anaemia and reviewed associated biochemical factors in RTRs with reference to British Transplantation Society (BTS) and KDIGO guidelines. The study was undertaken at a large NHS Trust in southwest UK caring for population of around 650,000. Methods: We conducted a retrospective review of RTRs under active follow-up in our centre using data from the local renal database (VitalData). The most recent haematological and biochemical results from the previous 12 months were analysed. Anaemia was defined as haemoglobin (Hb) ≤110 g/L. Descriptive statistics were used, including proportions and 95% confidence intervals (CIs). Results: A total of 318 RTRs were identified; 313 (98.4%) had complete full blood count data. The mean age was 57.7 ± 12.9 years, and 59% were male. Mean time since transplant was 10.1 ± 5.6 years. The median serum creatinine was 118 umol/L (IQR=95,163). 192 of 313 patients (61.3% ± 55.9-66.8%) were classed as CKD 3a-5 using eGFR. Table of results: Prevalence of Anaemia and Biochemical Abnormalities in RTRs Conclusion: - Despite suboptimal graft function in 61.3% of patients, anaemia prevalence was low (9.2%), indicating effective post-transplant monitoring. - Low serum ferritin was also low (4.0%), which could contribute to the low rates of anaemia in this population. - Folate (18.1%) and vitamin B12 (32.1%) deficiencies were common. - These deficiencies may contribute to elevated homocysteine levels and potential graft dysfunction. - Routine monitoring and targeted supplementation of haematinics should be considered to optimise graft and patient outcomes.Table of results: Prevalence of Anaemia and Biochemical Abnormalities in RTRs

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025b03h180v
Primary Topic
Erythropoietin and Anemia Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of Anaemia and Review of Associated Factors in Kidney Transplant Recipients: A Retrospective Analysis from a Single United Kingdom (UK) Centre

Adarsh Babu, Preetham Boddana, Geraldine O’Brien
Journal of the American Society of Nephrology
Erythropoietin and Anemia Treatment
article

Prevalence of Anaemia and Review of Associated Factors in Kidney Transplant Recipients: A Retrospective Analysis from a Single United Kingdom (UK) Centre

Adarsh Babu, Preetham Boddana, Geraldine O’Brien
article en

Abstract

Background: Renal transplantation is the optimal treatment for end-stage renal disease (ESRD), offering superior survival outcomes compared to dialysis. However, renal transplant recipients (RTRs) remain at high risk of anaemia, which may affect graft function and patient morbidity. This study assessed the prevalence of anaemia and reviewed associated biochemical factors in RTRs with reference to British Transplantation Society (BTS) and KDIGO guidelines. The study was undertaken at a large NHS Trust in southwest UK caring for population of around 650,000. Methods: We conducted a retrospective review of RTRs under active follow-up in our centre using data from the local renal database (VitalData). The most recent haematological and biochemical results from the previous 12 months were analysed. Anaemia was defined as haemoglobin (Hb) ≤110 g/L. Descriptive statistics were used, including proportions and 95% confidence intervals (CIs). Results: A total of 318 RTRs were identified; 313 (98.4%) had complete full blood count data. The mean age was 57.7 ± 12.9 years, and 59% were male. Mean time since transplant was 10.1 ± 5.6 years. The median serum creatinine was 118 umol/L (IQR=95,163). 192 of 313 patients (61.3% ± 55.9-66.8%) were classed as CKD 3a-5 using eGFR. Table of results: Prevalence of Anaemia and Biochemical Abnormalities in RTRs Conclusion: - Despite suboptimal graft function in 61.3% of patients, anaemia prevalence was low (9.2%), indicating effective post-transplant monitoring. - Low serum ferritin was also low (4.0%), which could contribute to the low rates of anaemia in this population. - Folate (18.1%) and vitamin B12 (32.1%) deficiencies were common. - These deficiencies may contribute to elevated homocysteine levels and potential graft dysfunction. - Routine monitoring and targeted supplementation of haematinics should be considered to optimise graft and patient outcomes.Table of results: Prevalence of Anaemia and Biochemical Abnormalities in RTRs

Journal of the American Society of NephrologyVol. 36(10S)
Gloucestershire Royal Hospital (GB)
Openalex Percentile: Top 51%
Erythropoietin and Anemia Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.